Revance Therapeutics, Inc. ( RVNC) - Key Metrics
Stock symbol RVNC is outdated, potentially delisted? Maybe it is available on other exchange?
RVNC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.56 | -$0.34 | -$0.39 | -$0.39 |
| 2024Q2 | $0.63 | -$0.36 | -$0.40 | -$0.40 |
| 2024Q1 | $0.57 | -$0.58 | -$0.72 | -$0.74 |
| 2023Q4 | $0.77 | -$0.62 | -$0.47 | -$0.49 |
| 2023Q3 | $0.66 | -$1.63 | -$0.59 | -$0.64 |
RVNC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -3.85 |
| 2024Q2 | ? | -1.78 |
| 2024Q1 | ? | -2.04 |
| 2023Q4 | ? | -3.56 |
| 2023Q3 | ? | -1.76 |
RVNC
Price: $3.65
52 week price:
Earnings Per Share: -3.34 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 728800
Ebitda: -30.2 millionMarket Capitalization: 381.0 million